Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 247 Nivolumab 144 Cyclophosphamide 137 Cisplatin 137 Paclitaxel 115 Carboplatin 111 Gemcitabine 100 Radiotherapy 86 Dexamethasone 84 Docetaxel 79 Ipilimumab 70 atezolizumab 68 Doxorubicin 63 Fluorouracil 60 Blood Specimen Collection 60 Bevacizumab 59 Etoposide 55 fludarabine 54 Rituximab 54 Oxaliplatin 52 Prednisone 51 Lenalidomide 51 Surveys and Questionnaires 50 Cetuximab 47 Standard of Care 46 Capecitabine 46 Radiosurgery 44 Magnetic Resonance Spectroscopy 44 lenvatinib 43 durvalumab 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tetrahydrouridine × 1 year × Clear all

NCT01534598 2026-02-10

FdCyd and THU for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡